Global Anti-infective drugs Market: Industry Analysis and forecast (2019 to 2026): By Type, Distribution channel, and Region

Global Anti-infective drugs Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of 5.1% during forecast period of 2019 to 2026. Global Anti-infective drugs Marke To know about the Research Methodology :- Request Free Sample Report Anti-infective drug is capable of acting against infection by inhibiting the spread of an infectious agent or by killing the infectious agent outright.It is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.

Global Anti-infective drugs Market Drivers and Restrains

The technological advances in anti-viral and antibiotic compounds are currently anti-infective drugs market, including Truvada and Valtrex, which are anti-HIV and anti-herpes therapy drugs, which are expected to fuel global anti-infective drug market. Developments such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems would propel the global anti-infective drugs market. Factors such as patent expiration of drugs, pricing pressures from regulators, and low returns on investments would hinder the global Anti-infective drugs market in forecast period. In January 2018, Melinta Therapeutics, Inc. launched its intravenous and oral formulations of Baxdela (delafloxacin) in the U.S. Baxdela is intended for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria including gram positive bacteria and gram negative bacteria. This step would drive the global Anti-infective drugs market and is anticipated to maintain its dominance in forecast period.

Global Anti-infective drugs Market key segmentation

The antibiotics market is further segmented by product into -lactams, quinolones, macrolides, aminoglycosides and others. The antivirals market is further segmented by therapeutic type into HIV AIDS therapeutics, hepatitis therapeutics, influenza therapeutics, and herpes therapeutics. The antifungals market is further segmented by product into azoles and others. The Antibacterial market is further segmented as Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines and Others Calcium channel blockers. Antiviral drug held highest share in terms of revenue of global Anti-infective drugs Market during the forecast period. rapid increase in the access to antiviral treatment of sexually transmitted diseases such as Hepatitis B and HIV/AIDS is expected to fuel this segment.. Increase in number of medical stores and hospitals are responsible for growth global Anti-infective drug market. Strong network of distribution channels around the countries have attributed to availability of anti-infectives that will affect the market in positive way. Also, major market players are focusing on expanding its geographical regions by focusing on distribution of anti-infectives in untapped markets of developing countries. The hospitals provide extensive patient treatment, care, quick reimbursement, and insurance policies owing to which patients opt for hospital pharmacies.

Global Anti-infective drugs Market regional analysis

North America dominated the global anti-infective drug market in 2018. Changing healthcare market scenario and high awareness among end-users such as clinicians and healthcare professionals are estimated key factors responsible for this growth rate. Furthermore, high purchasing power for expensive drugs and the presence of favorable reimbursement policies are further attributed to fuel the regional market during the forecast period. Asia-Pacific witnesses significant CAGR over the forecast period heading to technological advances in drug discovery. Growing geriatric population coupled with increased susceptibility to infections is expected to provide a potential growth platform in the forecast period. It was followed by Western Europe and then the other regions. Going forward, Africa and Middle East will be the fastest growing regions in this market. The objective of the report is to present comprehensive analysis of Global Anti-infective drugs Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Anti-infective drugs Market dynamics, structure by analyzing the market segments, and project the Global Anti-infective drugs Market size. Clear representation of competitive analysis of key players by Anti-infective drugs Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Anti-infective drugs Market make the report investor’s guide.

Scope of the Global Anti-infective drugs Market: Inquire before buying

Global Anti-infective drugs Market by product type

• Antibiotics • Antivirals • Antifungals • Antibacterial

Global Anti-infective drugs Market Distribution Channels

• Retail Pharmacy • Hospital Pharmacy • Other

Global Anti-infective drugs Market by region

• Asia Pacific • North America • Europe • Latin America • Middle East Africa

Key players operating on Global Anti-infective drugs Market

• Gilead Sciences, • GlaxoSmithKline, • Merck & Co, • Teva Pharmaceutical Industries Ltd., • Johnson & Johnson • Pfizer Inc. • Abbott Laboratories • Gilead Sciences, Inc. • Bristol-Myers Squibb Co. • Bayer Healthcare AG • AstraZeneca Plc. • Boehringer Ingelheim • Novartis AG • Astellas Pharma, Inc. • GlaxoSmithKline Plc. • Alcon Pharmaceuticals Ltd. • Sanofi-Aventis S.A. • Melinta Therapeutics, Inc. • F. Hoffmann-La Roche Ltd • Hetero • Mylan N.V. • Aurobindo Pharma • Cipla Inc • Laurus Labs Ltd • Sun Pharmaceutical Industries Ltd
Global Anti-infective drugs Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Anti-infective drugs Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Anti-infective drugs Market Analysis and Forecast 6.1. Global Anti-infective drugs Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Anti-infective drugs Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Anti-infective drugs Market Value Share Analysis, By Product 7.4. Global Anti-infective drugs Market Size (US$ Bn) Forecast, By Product 7.5. Global Anti-infective drugs Market Analysis, By Product 7.6. Global Anti-infective drugs Market Attractiveness Analysis, By Product 8. Global Anti-infective drugs Market Analysis and Forecast, By Distribution Channels 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Anti-infective drugs Market Value Share Analysis, By Distribution Channels 8.4. Global Anti-infective drugs Market Size (US$ Bn) Forecast, By Distribution Channels 8.5. Global Anti-infective drugs Market Analysis, By Distribution Channels 8.6. Global Anti-infective drugs Market Attractiveness Analysis, By Distribution Channels 9. Global Anti-infective drugs Market Analysis, by Region 9.1. Global Anti-infective drugs Market Value Share Analysis, by Region 9.2. Global Anti-infective drugs Market Size (US$ Bn) Forecast, by Region 9.3. Global Anti-infective drugs Market Attractiveness Analysis, by Region 10. North America Anti-infective drugs Market Analysis 10.1. Key Findings 10.2. North America Anti-infective drugs Market Overview 10.3. North America Anti-infective drugs Market Value Share Analysis, By Product 10.4. North America Anti-infective drugs Market Forecast, By Product 10.4.1. Antibiotics, 10.4.2. Antivirals, 10.4.3. Antifungals 10.4.4. Antibacterial 10.5. North America Anti-infective drugs Market Value Share Analysis, By Distribution Channels 10.6. North America Anti-infective drugs Market Forecast, By Distribution Channels 10.6.1. Retail Pharmacy 10.6.2. Hospital Pharmacy 10.6.3. Other 10.7. North America Anti-infective drugs Market Value Share Analysis, by Country 10.8. North America Anti-infective drugs Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Anti-infective drugs Market Analysis, by Country 10.10. U.S. Anti-infective drugs Market Forecast, By Product 10.10.1. Antibiotics, 10.10.2. Antivirals, 10.10.3. Antifungals 10.10.4. Antibacterial 10.11. U.S. Anti-infective drugs Market Forecast, By Distribution Channels 10.11.1. Retail Pharmacy 10.11.2. Hospital Pharmacy 10.11.3. Other 10.12. Canada Anti-infective drugs Market Forecast, By Product 10.12.1. Antibiotics, 10.12.2. Antivirals, 10.12.3. Antifungals 10.12.4. Antibacterial 10.13. Canada Anti-infective drugs Market Forecast, By Distribution Channels 10.13.1. Retail Pharmacy 10.13.2. Hospital Pharmacy 10.13.3. Other 10.14. North America Anti-infective drugs Market Attractiveness Analysis 10.14.1. By Product 10.14.2. By Distribution Channels 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Anti-infective drugs Market Analysis 11.1. Key Findings 11.2. Europe Anti-infective drugs Market Overview 11.3. Europe Anti-infective drugs Market Value Share Analysis, By Product 11.4. Europe Anti-infective drugs Market Forecast, By Product 11.4.1. Antibiotics, 11.4.2. Antivirals, 11.4.3. Antifungals 11.4.4. Antibacterial 11.5. Europe Anti-infective drugs Market Value Share Analysis, By Distribution Channels 11.6. Europe Anti-infective drugs Market Forecast, By Distribution Channels 11.6.1. Retail Pharmacy 11.6.2. Hospital Pharmacy 11.6.3. Other 11.7. Europe Anti-infective drugs Market Value Share Analysis, by Country 11.8. Europe Anti-infective drugs Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Anti-infective drugs Market Analysis, by Country 11.10. Germany Anti-infective drugs Market Forecast, By Product 11.10.1. Antibiotics, 11.10.2. Antivirals, 11.10.3. Antifungals 11.10.4. Antibacterial 11.11. Germany Anti-infective drugs Market Forecast, By Distribution Channels 11.11.1. Retail Pharmacy 11.11.2. Hospital Pharmacy 11.11.3. Other 11.12. U.K. Anti-infective drugs Market Forecast, By Product 11.12.1. Antibiotics, 11.12.2. Antivirals, 11.12.3. Antifungals 11.12.4. Antibacterial 11.13. U.K. Anti-infective drugs Market Forecast, By Distribution Channels 11.13.1. Retail Pharmacy 11.13.2. Hospital Pharmacy 11.13.3. Other 11.14. France Anti-infective drugs Market Forecast, By Product 11.14.1. Antibiotics, 11.14.2. Antivirals, 11.14.3. Antifungals 11.14.4. Antibacterial 11.15. France Anti-infective drugs Market Forecast, By Distribution Channels 11.15.1. Retail Pharmacy 11.15.2. Hospital Pharmacy 11.15.3. Other 11.16. Italy Anti-infective drugs Market Forecast, By Product 11.16.1. Antibiotics, 11.16.2. Antivirals, 11.16.3. Antifungals 11.16.4. Antibacterial 11.17. Italy Anti-infective drugs Market Forecast, By Distribution Channels 11.17.1. Retail Pharmacy 11.17.2. Hospital Pharmacy 11.17.3. Other 11.18. Spain Anti-infective drugs Market Forecast, By Product 11.18.1. Antibiotics, 11.18.2. Antivirals, 11.18.3. Antifungals 11.18.4. Antibacterial 11.19. Spain Anti-infective drugs Market Forecast, By Distribution Channels 11.19.1. Retail Pharmacy 11.19.2. Hospital Pharmacy 11.19.3. Other 11.20. Rest of Europe Anti-infective drugs Market Forecast, By Product 11.20.1. Antibiotics, 11.20.2. Antivirals, 11.20.3. Antifungals 11.20.4. Antibacterial 11.21. Rest of Europe Anti-infective drugs Market Forecast, By Distribution Channels 11.21.1. Retail Pharmacy 11.21.2. Hospital Pharmacy 11.21.3. Other 11.22. Europe Anti-infective drugs Market Attractiveness Analysis 11.22.1. By Product 11.22.2. By Distribution Channels 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Anti-infective drugs Market Analysis 12.1. Key Findings 12.2. Asia Pacific Anti-infective drugs Market Overview 12.3. Asia Pacific Anti-infective drugs Market Value Share Analysis, By Product 12.4. Asia Pacific Anti-infective drugs Market Forecast, By Product 12.4.1. Antibiotics, 12.4.2. Antivirals, 12.4.3. Antifungals 12.4.4. Antibacterial 12.5. Asia Pacific Anti-infective drugs Market Value Share Analysis, By Distribution Channels 12.6. Asia Pacific Anti-infective drugs Market Forecast, By Distribution Channels 12.6.1. Retail Pharmacy 12.6.2. Hospital Pharmacy 12.6.3. Other 12.7. Asia Pacific Anti-infective drugs Market Value Share Analysis, by Country 12.8. Asia Pacific Anti-infective drugs Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Anti-infective drugs Market Analysis, by Country 12.10. China Anti-infective drugs Market Forecast, By Product 12.10.1. Antibiotics, 12.10.2. Antivirals, 12.10.3. Antifungals 12.10.4. Antibacterial 12.11. China Anti-infective drugs Market Forecast, By Distribution Channels 12.11.1. Retail Pharmacy 12.11.2. Hospital Pharmacy 12.11.3. Other 12.12. India Anti-infective drugs Market Forecast, By Product 12.12.1. Antibiotics, 12.12.2. Antivirals, 12.12.3. Antifungals 12.13. India Anti-infective drugs Market Forecast, By Distribution Channels 12.13.1. Retail Pharmacy 12.13.2. Hospital Pharmacy 12.13.3. Other 12.14. Japan Anti-infective drugs Market Forecast, By Product 12.14.1. Antibiotics, 12.14.2. Antivirals, 12.14.3. Antifungals 12.14.4. Antibacterial 12.15. Japan Anti-infective drugs Market Forecast, By Distribution Channels 12.15.1. Retail Pharmacy 12.15.2. Hospital Pharmacy 12.15.3. Other 12.16. ASEAN Anti-infective drugs Market Forecast, By Product 12.16.1. Antibiotics, 12.16.2. Antivirals, 12.16.3. Antifungals 12.16.4. Antibacterial 12.17. ASEAN Anti-infective drugs Market Forecast, By Distribution Channels 12.17.1. Retail Pharmacy 12.17.2. Hospital Pharmacy 12.17.3. Other 12.18. Rest of Asia Pacific Anti-infective drugs Market Forecast, By Product 12.18.1. Antibiotics, 12.18.2. Antivirals, 12.18.3. Antifungals 12.18.4. Antibacterial 12.19. Rest of Asia Pacific Anti-infective drugs Market Forecast, By Distribution Channels 12.19.1. Retail Pharmacy 12.19.2. Hospital Pharmacy 12.19.3. Other 12.20. Asia Pacific Anti-infective drugs Market Attractiveness Analysis 12.20.1. By Product 12.20.2. By Distribution Channels 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Anti-infective drugs Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Anti-infective drugs Market Overview 13.3. Middle East & Africa Anti-infective drugs Market Value Share Analysis, By Product 13.4. Middle East & Africa Anti-infective drugs Market Forecast, By Product 13.4.1. Antibiotics 13.4.2. Antivirals 13.4.3. Antifungals 13.4.4. Antibacterial 13.5. Middle East & Africa Anti-infective drugs Market Value Share Analysis, By Distribution Channels 13.6. Middle East & Africa Anti-infective drugs Market Forecast, By Distribution Channels 13.6.1. Retail Pharmacy 13.6.2. Hospital Pharmacy 13.6.3. Other 13.7. Middle East & Africa Anti-infective drugs Market Value Share Analysis, by Country 13.8. Middle East & Africa Anti-infective drugs Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Anti-infective drugs Market Analysis, by Country 13.10. GCC Anti-infective drugs Market Forecast, By Product 13.10.1. Antibiotics 13.10.2. Antivirals 13.10.3. Antifungals 13.10.4. Antibacterial 13.11. GCC Anti-infective drugs Market Forecast, By Distribution Channels 13.11.1. Retail Pharmacy 13.11.2. Hospital Pharmacy 13.11.3. Other 13.12. South Africa Anti-infective drugs Market Forecast, By Product 13.12.1. Antibiotics 13.12.2. Antivirals 13.12.3. Antifungals 13.12.4. Antibacterial 13.13. South Africa Anti-infective drugs Market Forecast, By Distribution Channels 13.13.1. Retail Pharmacy 13.13.2. Hospital Pharmacy 13.13.3. Other 13.14. Rest of Middle East & Africa Anti-infective drugs Market Forecast, By Product 13.14.1. Antibiotics, 13.14.2. Antivirals, 13.14.3. Antifungals 13.14.4. Antibacterial 13.15. Rest of Middle East & Africa Anti-infective drugs Market Forecast, By Distribution Channels 13.15.1. Retail Pharmacy 13.15.2. Hospital Pharmacy 13.15.3. Other 13.16. Middle East & Africa Anti-infective drugs Market Attractiveness Analysis 13.16.1. By Product 13.16.2. By Distribution Channels 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Anti-infective drugs Market Analysis 14.1. Key Findings 14.2. South America Anti-infective drugs Market Overview 14.3. South America Anti-infective drugs Market Value Share Analysis, By Product 14.4. South America Anti-infective drugs Market Forecast, By Product 14.4.1. Antibiotics, 14.4.2. Antivirals, 14.4.3. Antifungals 14.4.4. Antibacterial 14.5. South America Anti-infective drugs Market Value Share Analysis, By Distribution Channels 14.6. South America Anti-infective drugs Market Forecast, By Distribution Channels 14.6.1. Retail Pharmacy 14.6.2. Hospital Pharmacy 14.6.3. Other 14.7. South America Anti-infective drugs Market Value Share Analysis, by Country 14.8. South America Anti-infective drugs Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Anti-infective drugs Market Forecast, By Product 14.9.1. Antibiotics, 14.9.2. Antivirals, 14.9.3. Antifungals 14.9.4. Antibacterial 14.10. Brazil Anti-infective drugs Market Forecast, By Distribution Channels 14.10.1. Retail Pharmacy 14.10.2. Hospital Pharmacy 14.10.3. Other 14.11. Mexico Anti-infective drugs Market Forecast, By Product 14.11.1. Antibiotics, 14.11.2. Antivirals, 14.11.3. Antifungals 14.11.4. Antibacterial 14.12. Mexico Anti-infective drugs Market Forecast, By Distribution Channels 14.12.1. Retail Pharmacy 14.12.2. Hospital Pharmacy 14.12.3. Other 14.13. Rest of South America Anti-infective drugs Market Forecast, By Product 14.13.1. Antibiotics, 14.13.2. Antivirals, 14.13.3. Antifungals 14.13.4. Antibacterial 14.14. Rest of South America Anti-infective drugs Market Forecast, By Distribution Channels 14.14.1. Retail Pharmacy 14.14.2. Hospital Pharmacy 14.14.3. Other 14.15. South America Anti-infective drugs Market Attractiveness Analysis 14.15.1. By Product 14.15.2. By Distribution Channels 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Gilead Sciences 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. GlaxoSmithKline, 15.3.3. Merck & Co, 15.3.4. Teva Pharmaceutical Industries Ltd., 15.3.5. Johnson & Johnson 15.3.6. Pfizer Inc. 15.3.7. Abbott Laboratories 15.3.8. Gilead Sciences, Inc. 15.3.9. Bristol-Myers Squibb Co. 15.3.10. Merck and Co., Inc. 15.3.11. Bayer Healthcare AG 15.3.12. AstraZeneca Plc. 15.3.13. Boehringer IngelheimNovartis AG 15.3.14. Astellas Pharma, Inc. 15.3.15. GlaxoSmithKline Plc. 15.3.16. Alcon Pharmaceuticals Ltd. 15.3.17. Sanofi-Aventis S.A. 15.3.18. Johnson and Johnson 15.3.18. F. Hoffmann-La Roche Ltd 15.3.19. Hetero 15.3.20. Mylan N.V. 15.3.21. Aurobindo Pharma 15.3.22. Cipla Inc 15.3.23. Laurus Labs Ltd 15.3.24. Sun Pharmaceutical Industries Ltd 16. Primary Key Insights

About This Report

Report ID 36720
Category Healthcare
Published Date Nov 2019
Updated Date Sep 2020
Contact Us